Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is evaluated at ...
Los Angeles, USA, April 12, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends DelveInsight’s ...
The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides - 2021 to 2025" report has been added to ...
ZUG, Switzerland and CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...
CRISPR Therapeutics’ two independent Phase 1 clinical trials assessing the safety and efficacy of several dose levels of CTX130, for the treatment of both solid tumors and certain hematologic ...
The stock's performance looks even more underwhelming in the context of the 26.9% growth that the S&P 500 index managed to post across the year's trading. While the benchmark index managed to post ...
Labroots invites you to the 4th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision ...
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application (Biomedical, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results